Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31
Phase 43

Trial Status

Completed4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT00304161Phase 4Completed
Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease
Depressive DisorderParkinson Disease
Principalinvestigator
NCT00898807Phase 3Completed
Citalopram for Agitation in Alzheimer's Disease
AgitationAlzheimer's Disease
Principalinvestigator
NCT01052831Phase 4Completed
Naltrexone for Impulse Control Disorders in Parkinson's Disease
Impulse Control DisorderParkinson Disease
Principalinvestigator
NCT01519271Phase 4Completed
Mild Cognitive Impairment in Parkinson's Disease
Mild Cognitive ImpairmentParkinson's Disease
Principalinvestigator

Research Network

Collaboration Network

15 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Rosenberg, MD

Johns Hopkins University

Moderately Similar
4 trials

Shared therapeutic areas:

Alzheimer DiseaseAgitationMild Cognitive Impairment

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score34%

Lon Schneider, MD

University of Southern California Keck School of Medicine Memory and Aging Center

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Constantine Lyketsos, MD, MHS

Johns Hopkins University

Related
2 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Bruce Pollock, MD

Centre for Addiction and Mental Health

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

David Shade, Esq

Johns Hopkins University

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Anton Porsteinsson, MD

University of Rochester

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Davengere Devanand, MD

Columbia University

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Jerome Yesavage, MD

Stanford University

Related
2 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Jacobo Mintzer, MD

Medical University of South Carolina Alzheimer's Research and Clinical Programs

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Alzheimer DiseaseParkinson DiseaseDepressive Disorder
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00304161Phase 4PrincipalInvestigator

Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

Depressive DisorderParkinson Disease
Completed
NCT00898807Phase 3PrincipalInvestigator

Citalopram for Agitation in Alzheimer's Disease

AgitationAlzheimer's Disease
Completed
NCT01052831Phase 4PrincipalInvestigator

Naltrexone for Impulse Control Disorders in Parkinson's Disease

Impulse Control DisorderParkinson Disease
Completed
NCT01519271Phase 4PrincipalInvestigator

Mild Cognitive Impairment in Parkinson's Disease

Mild Cognitive ImpairmentParkinson's Disease
Completed

All 4 trials loaded